miRNA-mediated risk for schizophrenia in 22q11.2 deletion syndrome
In humans, the most common genomic disorder is a hemizygous deletion of a 1.5 to 3 Mb region of chromosome 22q11.2. The resultant 22q11.2 deletion syndrome (22q11.2DS) can affect multiple organ systems, and most notably includes cardiac, craniofacial, and neurodevelopmental defects. Individuals wi...
Main Authors: | Linda M Brzustowicz, Anne S Bassett |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-12-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fgene.2012.00291/full |
Similar Items
-
Schizophrenia Risk Mediated by microRNA Target Genes Overlapped by Genome-Wide Rare Copy Number Variation in 22q11.2 Deletion Syndrome
by: Shengjie Ying, et al.
Published: (2022-04-01) -
MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review
by: Andreas J. eForstner, et al.
Published: (2013-12-01) -
Upregulation of DGCR8, a Candidate Predisposing to Schizophrenia in Han Chinese, Contributes to Phenotypic Deficits and Neuronal Migration Delay
by: Yan Bi, et al.
Published: (2022-04-01) -
MiRNAs of peripheral blood as the biomarker of schizophrenia
by: Kuanjun He, et al.
Published: (2017-08-01) -
Mapping miRNA research in schizophrenia: a scientometric review
by: Lim, Mengyu, et al.
Published: (2023)